Ventyx Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,448 |
Gross Profit | -323 | -356 | 724 | |
EBITDA | -22,768 | -29,010 | -29,741 | -32,103 |
EBIT | -22,829 | -29,333 | -30,097 | -32,418 |
Net Income | -22,829 | -26,987 | -27,440 | -29,351 |
Net Change In Cash | 0 | 0 | 0 | 1,448 |
Free Cash Flow | -17,558 | -21,319 | -25,734 | -23,255 |
Cash | 31,970 | 32,301 | 28,076 | 27,260 |
Basic Shares | 71,304 | 71,198 | 71,131 | 70,810 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,348 | -941 | -470 | -30 |
EBITDA | -147,102 | -207,053 | -112,666 | -83,617 |
EBIT | -148,450 | -207,994 | -113,136 | -83,647 |
Net Income | -135,122 | -192,962 | -108,426 | -83,746 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -5,930 | 70,547 | ||
Free Cash Flow | -131,114 | -167,036 | -99,046 | -38,912 |
Cash | 27,260 | 51,579 | 64,819 | 70,791 |
Basic Shares | 68,478 | 58,542 | 52,471 | 50,408 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.32 |
2025-06-30 | -$0.38 |
2025-03-31 | -$0.39 |
